Nuveen Asset Management’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$213K Hold
69,962
﹤0.01% 3195
2024
Q3
$348K Hold
69,962
﹤0.01% 3115
2024
Q2
$409K Buy
+69,962
New +$409K ﹤0.01% 3054